PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) OR METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISAESE (MASLD)-RELATED CIRRHOSIS IN THE UNITED STATES

被引：0
|
作者：
Owrangi, Soroor
Hashida, Ryuki
Paik, James M.
Golabi, Pegah
De Avila, Leyla
Younossi, Zobair M.
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1580
引用
收藏
页码：S1648 / S1649
页数：2
相关论文
共 50 条
  • [1] METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) AND NONALCOHOLIC FATTY LIVER DISEASE (NAFLD): CONCORDANCE OF CLINICAL PROFILES AND NON-INVASIVE TESTS PERFORMANCE
    Stepanova, Maria
    De Avila, Leyla
    Racila, Andrei
    Golabi, Pegah
    Nader, Fatema
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2024, 166 (05) : S1558 - S1558
  • [2] Concordance between metabolic dysfunction-associated steatotic liver disease and nonalcoholic fatty liver disease
    Suzuki, Keito
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Takahashi, Yuka
    Yamazaki, Yudai
    Uchihara, Naoki
    Tanaka, Yuki
    Miyamoto, Haruka
    Yamada, Michiko
    Keitoku, Taisei
    Okada, Risa
    Higuchi, Mayu
    Takaura, Kenta
    Tanaka, Shohei
    Maeyashiki, Chiaki
    Yasui, Yutaka
    Tsuchiya, Kaoru
    Nakanishi, Hiroyuki
    Izumi, Namiki
    HEPATOLOGY RESEARCH, 2024, 54 (06) : 600 - 605
  • [3] Diagnosis and evaluation of metabolic dysfunction associated steatotic liver disease (MASLD)
    Canivet, C. M.
    Faure, S.
    REVUE DE MEDECINE INTERNE, 2024, 45 (01): : 41 - 47
  • [4] Prevalence of Nonalcoholic Fatty Liver Disease [NAFLD] and Metabolic dysfunction associated Fatty Liver Disease [MAFLD] in patients with Irritable Bowel Syndrome [IBS]
    Md. Musab Khalil
    Sirajam Munira
    Md. Mahbubul Alam
    Al Mahmood Appolo
    Musatafa Md. Abu Sayeed
    Atikul Islam
    Narwana Khaleque
    Mohammad Faisal
    Arifa Tasnim
    Ruma Najnin
    Mahmudur Rahman
    Enamul Karim
    Md. Golam Kibria
    SN Comprehensive Clinical Medicine, 6 (1)
  • [5] Beyond Nonalcoholic Fatty Liver Disease: The Expansive Realm of Metabolic Dysfunction-associated Steatotic Liver Disease
    Samadarshi, Samir
    Kumar, Dharmendra
    Manrai, Manish
    Dawra, Saurabh
    Srivastava, Sharad
    Chandra, Alok
    JOURNAL OF MARINE MEDICAL SOCIETY, 2025, 27 (01) : 54 - 58
  • [6] Burden of Nonalcoholic Fatty Liver Disease (NAFLD) in the United States
    Sanyal, Arun J.
    Estes, Chris
    Razavi, Homie
    HEPATOLOGY, 2016, 64 : 532A - 532A
  • [7] Embracing Change: From Nonalcoholic Fatty Liver Disease to Metabolic Dysfunction-Associated Steatotic Liver Disease Under the Steatotic Liver Disease Umbrella
    Noureddin, Mazen
    Wei, Lai
    Castera, Laurent
    Tsochatzis, Emmanuel A.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (01) : 9 - 11
  • [8] Epidemiology of metabolic dysfunction-associated steatotic liver disease (MASLD) and alcohol-related liver disease (ALD)
    Wong, Robert J.
    METABOLISM AND TARGET ORGAN DAMAGE, 2024, 4 (04):
  • [9] NAFLD vs MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)-Why the Need for a Change of Nomenclature?
    Gastaldelli, Amalia
    Newsome, Philip N.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025,
  • [10] Trends in the Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in the United States
    Wong, Robert J.
    Cheung, Ramsey
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (03) : E610 - E613
12345